Muscle News and Research

RSS

Loyola researcher receives $1.3 million NIH grant to study key heart protein

Loyola University Health System researcher Sakthivel Sadayappan, PhD, has been awarded a four-year, $1.3 million grant from the National Institutes of Health to study a protein that is critical for the normal functioning of the heart.

23 Dec 2010

Minorities with MS may face risk of developing depressive symptoms

Multiple sclerosis can cause significant physical impairment, including fatigue, pain, muscle spasms, tremors and dizziness. For many with MS, the disease wreaks havoc with emotional well-being, too, and according to a new study, minorities might especially be at risk for developing depressive symptoms.

23 Dec 2010

Top ten advances in cardiovascular, stroke research in 2010

Research on reducing risks, improving medical treatment and improving lifestyle behaviors to fight the battle against heart disease and stroke are among the key scientific findings that make up this year's top cardiovascular and stroke research recognized by the American Heart Association/American Stroke Association.

22 Dec 2010

Spinal Botox injection reduces pain

Botulinum neurotoxin type A (BoNT/A)—better known as Botox—reduces responses to an inflammation-related pain stimulus when injected into the spinal canal in mice, reports a study in the January issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

22 Dec 2010

Amorcyte reports AMR-001 phase I trial results in heart attack patients

The American Heart Journal today reported results of a clinical trial evaluating Amorcyte, lead product candidate, AMR-001 for the treatment of damaged heart muscle following acute myocardial infarction.

22 Dec 2010

Verizon grants will eanble heart attack patients to receive life-saving treatments more quickly

Heart attack patients can receive life-saving treatments more quickly thanks to $100,000 in grants from the Verizon Foundation to the Foundation of UMDNJ for a program that enables heart attack patients to bypass the emergency room and go directly to the cardiac catheterization laboratory at UMDNJ-The University Hospital.

22 Dec 2010

Chronic fatigue syndrome not linked to virus

The latest research from the University College London, the Wellcome Trust Sanger Institute, and University of Oxford, England suggests that chronic fatigue syndrome (CFS) is not caused by the virus XMRV (xenotropic murine leukemia virus-related virus). The team says that earlier research that linked the virus to CFS was faulty because of contamination of mouse cell DNA samples in the laboratory.

21 Dec 2010

Researchers present definitive explanation of how fibrotic cells destroy human liver

In the latest of a series of related papers, researchers at the University of California, San Diego School of Medicine, with colleagues in Austria and elsewhere, present a new and more definitive explanation of how fibrotic cells form, multiply and eventually destroy the human liver, resulting in cirrhosis. In doing so, the findings upend the standing of a long-presumed marker for multiple fibrotic diseases and reveal the existence of a previously unknown kind of inflammatory white blood cell.

21 Dec 2010

DNA sequence variations linked with heart's electrical rhythm in several surprising regions

A study among almost 50,000 people worldwide has identified DNA sequence variations linked with the heart's electrical rhythm in several surprising regions among 22 locations across the human genome. The variants were found by an international consortium, including Johns Hopkins researchers, and reported Nov. 14 in the Nature Genetics advance online publication.

21 Dec 2010

Ovarian cancer tissue and healthy tissue smell different

György Horvath from the University of Gothenburg, Sweden, and researchers from the University of Gävle and KTH Royal Institute of Technology have been able to confirm in tests that ovarian cancer tissue and healthy tissue smell different. The results were published recently in the journal Future Oncology.

21 Dec 2010

Scientists boost protein supply to enhance muscle function, reduce nerve-dependent fatigue in mice

Researchers at Vanderbilt University have "engineered" a mouse that can run on a treadmill twice as long as a normal mouse by increasing its supply of acetylcholine, the neurotransmitter essential for muscle contraction.

21 Dec 2010

Exciting progress made in MS research during 2010

Exciting advances were made in 2010 in virtually every field of MS research. Progress toward finding new therapies for MS is illustrated by the availability of the first oral disease-modifying therapy for MS. Progress was also made toward finding ways to restore function and improving quality of life and specific MS symptoms through exercise, meditation, rehabilitation and medications, including the first therapy specifically approved to treat a symptom of MS (Ampyra).

20 Dec 2010

Research: Beetroot juice may allow patients with heart and lung-conditions to enjoy more active lives

New research into the health benefits of beetroot juice suggests it's not only athletes who can benefit from its performance enhancing properties - its physiological effects could help the elderly or people with heart or lung-conditions enjoy more active lives.

20 Dec 2010

Pediatric plastic surgeon reconstructs patient's jaw

Pediatric plastic surgeon Rohit Khosla, MD, had never seen a case like it: the 12-year-old boy's face ballooned with a rare, aggressive bone tumor. Although it was non-cancerous, the tumor was destroying the patient's jaw. Khosla knew he would need an innovative approach to save the boy's ability to chew.

17 Dec 2010

Study suggests blood test may detect persons with CKD

An infrequently used blood test can effectively identify individuals at increased risk of developing complications associated with chronic kidney disease (CKD), according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).

17 Dec 2010

MDA awards Repligen $1.4M for research of new compound with therapeutic potential for SMA

The Muscular Dystrophy Association today announced it has awarded $1.4 million in new research funding to the biopharmaceutical firm Repligen of Waltham, Mass., to complete the preclinical work needed to begin human clinical trials of a promising therapeutic compound for spinal muscular atrophy (SMA).

17 Dec 2010

New visualisation software tool for older people to understand mobility problems

Mobility challenges facing older people can now be better understood by clinicians, healthcare practitioners and design professionals, thanks to a new innovative software tool.

16 Dec 2010

Research: Stem cell culture on soft substrate maintain homogeneous pluripotent colonies

In a paper published in the journal PLoS One, the researchers demonstrated that culturing mouse embryonic stem cells on a soft gel rather than on a hard plate or dish keeps them in their pluripotent state, a ground state with the ability to become any type of tissue.

16 Dec 2010

MDA supports Repligen with $1.4M grant for RG3039 Spinal Muscular Atrophy development program

Repligen Corporation today announced that the Company has received $1,400,000 in research funding from the Muscular Dystrophy Association ("MDA") to support the ongoing development of RG3039 for Spinal Muscular Atrophy ("SMA"). RG3039, our lead compound, is an inhibitor of an RNA processing enzyme which targets increased production of SMN, a protein of deficient levels in patients with SMA.

15 Dec 2010

iTech Medical receives CE Mark approval for Muscle Pattern Recognition System

iTech Medical, Inc., a medical information technology company, announced today that it has received CE Mark approval for the commercial sale of the Company's Muscle Pattern Recognition (MPR) System in Europe. This approval allows for the marketing and sale of the device in the European Union (EU) and all countries recognizing the CE Mark.

15 Dec 2010

Muscle News and Research

Loyola researcher receives $1.3 million NIH grant to study key heart protein

Minorities with MS may face risk of developing depressive symptoms

Top ten advances in cardiovascular, stroke research in 2010

Spinal Botox injection reduces pain

Amorcyte reports AMR-001 phase I trial results in heart attack patients

Verizon grants will eanble heart attack patients to receive life-saving treatments more quickly

Chronic fatigue syndrome not linked to virus

Researchers present definitive explanation of how fibrotic cells destroy human liver

DNA sequence variations linked with heart's electrical rhythm in several surprising regions

Ovarian cancer tissue and healthy tissue smell different

Scientists boost protein supply to enhance muscle function, reduce nerve-dependent fatigue in mice

Exciting progress made in MS research during 2010

Research: Beetroot juice may allow patients with heart and lung-conditions to enjoy more active lives

Pediatric plastic surgeon reconstructs patient's jaw

Study suggests blood test may detect persons with CKD

MDA awards Repligen $1.4M for research of new compound with therapeutic potential for SMA

New visualisation software tool for older people to understand mobility problems

Research: Stem cell culture on soft substrate maintain homogeneous pluripotent colonies

MDA supports Repligen with $1.4M grant for RG3039 Spinal Muscular Atrophy development program

iTech Medical receives CE Mark approval for Muscle Pattern Recognition System

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News